ArticleMolecular medicine (Cambridge, Mass.)2019

Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia.

Alexander P de Porto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.